EIF2S1 anticorps

N° du produit ABIN1831340

L’anticorps anti-EIF2S1 Monoclonal Lapin est utilisé pour la détection de EIF2S1 dans des échantillons de Humain, Souris, Rat et Singe. Il a été validé pour WB, IHC et IP.

Aperçu rapide pour EIF2S1 anticorps (ABIN1831340)

Antigène: EIF2S1 (Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))

Reactivité: Humain, Souris, Rat, Singe

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp EIF2S1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP)

Clone: 11C1031

Détail du produit anti-EIF2S1 anticorps

Specificité: Endogenous levels of total eIF2a.

Purification: Purified

Immunogène: Recombinant human eIF2a.

Type of Immunogen: Recombinant protein

Isotype: IgG

Information d'application

Indications d'application: Approved: IHC, IP, WB (1:1000)

Usage: Western Blot: Incubate membrane with diluted antibody in 5 % BSA, 1X TBS, 0.1 % Tween-20 at 4C with gentle shaking, overnight.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: 10 mM sodium HEPES,  pH 7.5, 150 mM sodium chloride, 100 μg/mL BSA, less than 0.02 % sodium azide, 50 % glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: 4 °C,-20 °C

Stockage commentaire: May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.

Détails sur EIF2S1

Antigène: EIF2S1 (Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))

Autre désignation: EIF2S1

Sujet: Name/Gene ID: EIF2S1

Synonyms: EIF2S1, EIF-2-alpha, EIF-2alpha, EIF2 alpha, EIF2, EIF-2, EIF-2A

ID gène: 1965

UniProt: P05198

Pathways: Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C